Try our corporate solution for free!
(212) 419-8286

Public readiness to take a COVID-19 vaccine in China 2020

A global survey on attitudes towards coronavirus COVID-19 vaccinations found out that Chinese people appeared to be less opposed to these newly developed vaccines. As per the survey results generated in December 2020, about 61 percent of the Chinese respondents said that they would take the coronavirus vaccines when the vaccines became available to them.

Share of respondents who would like to take a COVID-19 vaccine in China as of December 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

In cooperation with
Release date

January 2021



Survey time period

7 to14 December, 2020

Number of respondents

1,016 respondents

Method of interview

Online survey

Supplementary notes

Original survey question:
If and when a Coronavirus (COVID-19) vaccine becomes available, will you get vaccinated?

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus (COVID-19) in China"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.